Prognosis depends on the extent of cardiac amyloidosis coupled with factors such as the patient’s age at symptom onset, the time between initial symptoms and diagnosis, and the specific TTR mutation in ATTRv. This evidence concerns the gene TTR and cardiac amyloidosis.